Skip to content

Contact +44 (0) 20 7060 7474 email us

Healthcare

Incyte Corporation - Financial and Strategic Analysis Review

 

Publication Date June 2009
Publisher Global Markets Direct
Product Type Report
Pages 17
ISBN Number not applicable
Product Code GMD02150

Price

£83.00
approximately: $126 | €93

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Incyte Corporation - Financial and Strategic Analysis Review

Incyte Corporation (Incyte) is engaged in discovery and development of small molecule drugs to treat serious unmet medical needs in the field of oncology, inflammation, diabetes and human immunodeficiency virus (HIV). Its products include INCB18424, INCB28050, INCB13739, INCB7839 for Inflammation, Hematologic Malignancies, and Solid Tumors; INCB28060, INCB24360 for treatment of cancer; INCB19602 for type 2 diabetes; INCB9471 and INCB15050 for treatment of HIV. The company is headquartered in Wilmington in Delaware, United States.

Global Markets Direct's Incyte Corporation - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Incyte Corporation. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

  • Provides key company information for business intelligence needs.
  • The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

  • A quick "one-stop-shop" to understand the company.
  • Enhance business/sales activities by understanding customers' businesses better.
  • Get detailed information and financial and strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitor's weaknesses and target the market opportunities available to them.
  • Compare your company's financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

  • List of Tables
  • List of Figures
    • Key Facts
    • Business Description
    • Major Products and Services
    • History
    • SWOT Analysis
    • SWOT Analysis - Overview
    • Incyte Corporation - Strengths
    • Incyte Corporation - Strengths - Sturdy Research and Development Activities
    • Incyte Corporation - Strengths - Strong Liquidity Position
    • Incyte Corporation - Weaknesses
    • Incyte Corporation - Weaknesses - Lack of Manufacturing Facilities
    • Incyte Corporation - Weaknesses - History of Operating Losses
    • Incyte Corporation - Opportunities
    • Incyte Corporation - Opportunities - Broad Product Pipeline
    • Incyte Corporation - Opportunities - Agreement with Pfizer
    • Incyte Corporation - Opportunities - Changing Demographics
    • Incyte Corporation - Threats
    • Incyte Corporation - Threats - Highly Competitive Environment
    • Incyte Corporation - Threats - Changing Political Climate in the US
    • Incyte Corporation - Threats - Tightening of FDA's Regulatory Oversight
    • Key Competitors
    • Key Employees
    • Key Employee Biographies
    • Company Statement
    • Locations And Subsidiaries
    • Locations And Subsidiaries - Head Office
    • Locations And Subsidiaries - Other Locations & Subsidiaries
    • Financial Ratios
    • Financial Ratios - Capital Market Ratios
    • Financial Ratios - Annual Ratios
    • Financial Ratios - Interim Ratios
    • Financial Ratios - Ratio Charts
  • Appendix
    • Methodology
    • Ratio Definitions
    • About Global Markets Direct
    • Contact Us
    • Disclaimer
  • List of Tables
    • Incyte Corporation, Key Facts
    • Major Products and Services
    • Incyte Corporation, History
    • Incyte Corporation, Key Employees
    • Incyte Corporation, Key Employee Biographies
    • Incyte Corporation, Subsidiaries
    • Incyte Corporation, Ratios based on current share price
    • Incyte Corporation, Annual Ratios
    • Incyte Corporation, Interim Ratios
    • Currency Codes
    • Capital Market Ratios
    • Equity Ratios
    • Profitability Ratios
    • Cost Ratios
    • Liquidity Ratios
    • Leverage Ratios
    • Efficiency Ratios
  • List of Figures
    • Incyte Corporation, Ratio Charts
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Contains SWOT Analysis